[go: up one dir, main page]

NO2019032I1 - Treosulfan - Google Patents

Treosulfan

Info

Publication number
NO2019032I1
NO2019032I1 NO2019032C NO2019032C NO2019032I1 NO 2019032 I1 NO2019032 I1 NO 2019032I1 NO 2019032 C NO2019032 C NO 2019032C NO 2019032 C NO2019032 C NO 2019032C NO 2019032 I1 NO2019032 I1 NO 2019032I1
Authority
NO
Norway
Prior art keywords
treosulfan
agents
administered
stem cells
combination
Prior art date
Application number
NO2019032C
Other languages
English (en)
Original Assignee
Medac Ges Fuer Klinische Spezialpraeparate Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medac Ges Fuer Klinische Spezialpraeparate Mbh filed Critical Medac Ges Fuer Klinische Spezialpraeparate Mbh
Publication of NO2019032I1 publication Critical patent/NO2019032I1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO2019032C 1999-11-05 2019-07-23 Treosulfan NO2019032I1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19953517A DE19953517C1 (de) 1999-11-05 1999-11-05 Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation
PCT/EP2000/010871 WO2001032154A2 (de) 1999-11-05 2000-11-03 Verwendung von treosulfan zur konditionierung von patienten vor knochenmarktransplantation oder blutstammzelltransplantation

Publications (1)

Publication Number Publication Date
NO2019032I1 true NO2019032I1 (no) 2019-07-23

Family

ID=7928187

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20022109A NO329616B1 (no) 1999-11-05 2002-05-02 Anvendelse av treosulfan for fremstilling av et farmasøytisk preparat til bruk i forbindelse med allogen transplantasjon av benmarg eller hematopoetiske stamceller
NO2019032C NO2019032I1 (no) 1999-11-05 2019-07-23 Treosulfan

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20022109A NO329616B1 (no) 1999-11-05 2002-05-02 Anvendelse av treosulfan for fremstilling av et farmasøytisk preparat til bruk i forbindelse med allogen transplantasjon av benmarg eller hematopoetiske stamceller

Country Status (16)

Country Link
US (1) US7199162B1 (no)
EP (1) EP1227808B1 (no)
JP (1) JP4846151B2 (no)
AT (1) ATE251455T1 (no)
AU (1) AU777527B2 (no)
BG (1) BG65845B1 (no)
CA (1) CA2389896C (no)
CZ (1) CZ299701B6 (no)
DE (2) DE19953517C1 (no)
EA (1) EA004543B1 (no)
ES (1) ES2208435T3 (no)
HU (2) HU227332B1 (no)
NO (2) NO329616B1 (no)
PL (1) PL212132B1 (no)
UA (1) UA73961C2 (no)
WO (1) WO2001032154A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237146A1 (de) 2002-08-13 2004-03-04 Medac Gesellschaft für klinische Spezialpräparate mbH Verwendung von Treosulfan und Derivaten davon zur Behandlung der Multiplen Sklerose
ES2964602T3 (es) 2018-09-26 2024-04-08 Medac Ges Fuer Klinische Spezialpraeparate Mbh Liofilizado de treosulfano
EP3856252A1 (en) 2018-09-26 2021-08-04 medac Gesellschaft für klinische Spezialpräparate mbH Solution comprising treosulfan
US20210387945A1 (en) * 2018-09-26 2021-12-16 Medac Gesellschaft Für Klinische Spezialpraparate MBH Crystalline form of treosulfan

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376546A (en) * 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
DE4421391C1 (de) * 1994-06-18 1995-11-30 Gsf Forschungszentrum Umwelt Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression
AU2980900A (en) * 1999-02-04 2000-08-25 General Hospital Corporation, The Methods for human allografting

Also Published As

Publication number Publication date
JP4846151B2 (ja) 2011-12-28
NO20022109L (no) 2002-07-01
PL356240A1 (en) 2004-06-28
CZ20021562A3 (cs) 2002-10-16
AU777527B2 (en) 2004-10-21
NO20022109D0 (no) 2002-05-02
EP1227808A2 (de) 2002-08-07
ATE251455T1 (de) 2003-10-15
BG106772A (bg) 2003-02-28
BG65845B1 (bg) 2010-03-31
EP1227808B1 (de) 2003-10-08
HU227332B1 (en) 2011-03-28
EA004543B1 (ru) 2004-06-24
DE19953517C1 (de) 2001-08-09
AU1391801A (en) 2001-05-14
HUS1900041I1 (hu) 2019-10-28
WO2001032154A3 (de) 2002-01-24
EA200200535A1 (ru) 2002-10-31
NO329616B1 (no) 2010-11-22
ES2208435T3 (es) 2004-06-16
CZ299701B6 (cs) 2008-10-22
WO2001032154A2 (de) 2001-05-10
HUP0203277A2 (en) 2003-01-28
UA73961C2 (uk) 2005-10-17
JP2003513034A (ja) 2003-04-08
DE50004024D1 (de) 2003-11-13
US7199162B1 (en) 2007-04-03
PL212132B1 (pl) 2012-08-31
CA2389896C (en) 2007-04-10
CA2389896A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
NO2019032I1 (no) Treosulfan
DE69937888D1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
IL140710A0 (en) Pulmonary delivery of active agents
SI0882021T1 (en) New phenanthridines
HUP9903072A2 (hu) 5,7-Dihidroxi-kromán-4-on-származékok az immunválasz elnyomására
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
ES2175079T3 (es) Derivados de indol utiles como inhibidores de cgmp-pde.
DK0975634T3 (da) Fungicide trifluorphenyl-triazolpyrimidiner
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
ATE514771T1 (de) Haartransplantation
DK1147088T3 (da) 6-arylphenanthridiner med PDE-IV-inhiberende aktivitet
BR0107544A (pt) Composição de promoção de secreção de bile
BR0009194A (pt) Composição do resorcinol
DK0793503T3 (da) Anvendelse af hepatocyt-vækstfaktor til inducering af profilerering og differentiering af hemotopoietiske celler
DE60033416D1 (de) Verwendung von hypoestoxiden als antiparasitäre mittel
PT1244614E (pt) Inibidores de triptase
ATE311104T1 (de) Trägerlösung für verglasbare konzentrationen von gefrierschutzmitteln und gefrierschutzmittel- mischungen
DK1194158T3 (da) Anvendelse af UK 114-proteiner til hæmning af organtransplantatafstödning
PL343848A1 (en) Novel benzimidazoles and benzoxazoles
ES2186782T3 (es) Uso de derivados de tropolona como inhibidores de la enzima inositol-monofosfatasa.